Look for:

Our offer for

Prémiový dluhový cenný papír PHARMA AUTOCALL


ISIN:
XS2248369535

Date: 2021/01/19 00:00:00
Bid Ask
99.99 -
Difference 0.05% (0.05)

General attributes

Type of bondStructured bonds and notes
Bond stylesenior
Issuer typecorporate
Country of issueDE
Current coupon0.000%
Coupon stylevariable
Coupon payment date2025/12/22
Coupon payment periodat maturity
Yield to maturity p.a. (before capital gains tax)-
Value date2020/12/21
Maturity2025/12/22
Repayment value0.00
CurrencyCZK
Nominal value10,000
Capital gains tax-
Accrued Interest0.00
Investor tolerance5 (scale 1-7)
Last trading day2025/12/12

PDF Downloads

CZ FlyerPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



The chart is composed of values which are the arithmetic average values of bid / ask (MID) from previous working day. Performances under 12 month have only little informative value. Information about previous performance does not guarantee future performance.
Source: Česká spořitelna, a. s.
Advantages Details you should be aware of

What does Prémiový dluhový cenný papír Pharma Autocall offer?

  • Possibility to obtain an attractive yield of up to 31.25% in 5 years.
  • PDCP PHARMA AUTOCALL can be automatically repaid early with the payout of an interesting yield of 6.25% (see Note) already after the first year or at any of the following annual observations. The total yield is then 6.25% (see Note) for each year that elapsed since the issue date.
  • Fixing the average initial value of the monitored index reduces the risk of bad timing. This value is determined as an average of the closing index prices for three consecutive days.
  • Interesting barrier level of 60% of the average initial value of the monitored index for payout of the nominal value of the Premium Bond at the date of closing monitoring. 
  • Barrier for automatic early repayment decreasing over in time: 100% (after a year), 95% (after two years), 90% (after three years), 85% (after four years).
  • PDCP PHARMA AUTOCALL is issued in Czech crowns, the investor does not bear currency risk. 
  • Electronic version of the Basic Prospectus is published on the Issuer´s website https://www.goldmansachs.com/ or on www.investicnicentrum.cz/prospekty.
  • Electronic version of the Notification of Key Information is published on the website   https://www.goldmansachs.com/ or you can find it on the investment portal www.investicnicentrum.cz.

-----------------------------------------------------------------
Note: Any potential yields from PDCP PHARMA AUTOCALL are paid in a lump sum at its early or regular maturity date, the consolidated interest is not claimed.

  • PDCP PHARMA AUTOCALL does not guarantee return on the invested amount and the investor may lose the whole investment or part of it.
  • The issuer is Goldman, Sachs & Co. Wertpapier GmbH
  • The return of 100% of the nominal value of the Premium Bond at the maturity date depends on the market exchange rate trend of the MSCI World IMI New Pharma Select 5% Decrement index.
  • If at the date of fixing the closing value of the index it falls below the barrier of 60% of its average initial value, no yield shall be paid out at the maturity date and the holder of PDCP PHARMA AUTOCALL shall lose more than 40% of the invested money.
  • The holder of PDCP PHARMA AUTOCALL bears the credit risk of the issuer and the guarantor.
  • The total yield is paid out in a single sum for the real duration of PDCP PHARMA AUTOCALL at the regular maturity date or at the date of automatic early repayment.
  • PDCP PHARMA AUTOCALL is subject to English law.
  • Guarantor: The Goldman Sachs Group, Inc. (S&P's BBB+ / Moody's A3 / Fitch A)
  • Underlying asset: index MSCI World IMI New Pharma Select 5% Decrement Index (prices are publicly available on MSCI websites)                
  • Subscription period: 19 November 2020 (10.00) – 14 December 2020 (16.00)
  • Price at subscription: 100%, without a fee
  • Dates of fixing the initial and closing value of the index, dates of possible automatic early repayment and dates of monitoring can be found in the leaflet.
  • Barrier for payout of the nominal value of PDCP PHARMA AUTOCALL at the closing monitoring date: 60% of average initial value of MSCI World IMI New Pharma Select 5% Decrement Index
  • Product costs valid at the subscription starting date: You will find the exact expression of product costs in PDCP PHARMA AUTOCALL Subscription Instruction): 0.60% annually

Description

PDCP PHARMA AUTOCALL with the option of automatic early repayment provides opportunity to gain an attractive annual yield in the amount of 6.25% (see Note). The total yield for its five-year duration may then reach up to 31.25%.

The payout of the yield and nominal value of PDCP PHARMA AUTOCALL is derived from the trend of the MSCI World IMI New Pharma Select 5% Decrement share index.  The structure of PDCP PHARMA AUTOCALL also makes early repayment and payout of an attractive yield possible if there is a slight fall or stagnation of the underlying index. The product may already end after the first year and then every year for its duration until the maturity date.

Payment notes

How does the Prémiový dluhový cenný papír PHARMA AUTOCALL work?

  • The payout of the yield and nominal value of PDCP PHARMA AUTOCALL depends on the trend of the MSCI World IMI New Pharma Select 5% Decrement index.
  • For its duration there may be an early automatic repayment of PDCP PHARMA AUTOCALL already after the first year or at any of the following annual observations, if the value of the monitored index at the observation date is equal to or higher than the comparative value of the underlying index at the relevant observation date.
  • If the condition for automatic early repayment is not met, PDCP PHARMA AUTOCALL continues to the next date of possible repayment.
  • If PDCP PHARMA AUTOCALL is automatically repaid early, the investor shall receive its nominal value and a yield of 6.25% (see Note) for every year that elapsed since the issue date.
    You will find the example in the leaflet.
  • If the automatic early repayment is not made and at the date of fixing the closing value of the observed index its value does not fall below the barrier of 60% of its average initial value, 100% of the nominal value of PDCP PHARMA AUTOCALL and a total yield of 5 x 6.25% = 31.25% (see Note) shall be paid out at the maturity date.
  • If the automatic early repayment is not made and at the date of fixing the closing value of the index its value falls below the barrier of 60% of its average initial value, 100% of PDCP PHARMA AUTOCALL nominal value decreased by the index loss that was recorded from the date of fixing its average initial value until the date of fixing its closing value shall be paid out at its maturity date. The investor shall lose more than 40% of the investment and no yield shall be paid out.
    You will find the example in the leaflet.

Settlement

  • The maturity date shall be 22 December 2025
  • Česká spořitelna pays out the yield and the nominal value 
  • It takes three working days to settle the buying and selling of the Premium Bond

Secondary market

  • Minimum purchased quantity: 1 piece
  • Price for the provision of redemption: 2% of the transaction volume
  • Liquidity: daily according to current market prices published in the Exchange Rate List of Česká spořitelna, a.s.

-----------------------------------------
Note: Any potential yields from PDCP PHARMA AUTOCALL are paid in a lump sum at its early or regular maturity date, the consolidated interest is not claimed.
Note 2: Risk weight: on a scale of increasing values from 1 to 7, where value 1 represents the potentially lowest risk and yield, and value 7 the potentially highest risk and yield provided that you keep the product until the maturity date. The actual risk may differ substantially if you sell early. The product’s risk weight is a guide for comparing the rate of risk of this product in comparison with other products. It shows what the likelihood is of you losing money as a consequence of fluctuations on markets or that the issuer and guarantor will not be able to meet their commitments.


Underlying


Know-How

 
In our know-how area you can find all relevant details on the different types of bonds. The tutorial gives you selected information about the functionality of bonds and assists you in making your investment decision. In our glossary we explain the most important keywords and within the FAQ section you can find answers to the most common questions concerning this topic.




Accept

We use cookies and web analysis software to give you the best possible experience on our website. By continuing to browse this website, you consent for these tools to be used. For more details and how to opt out of these, please read our Data protection policy.

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer